A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/352 (2006.01) A61K 41/00 (2006.01) A61P 43/00 (2006.01)
Patent
CA 2546445
Administration of a modulator of cell cycle checkpoint activation, which is preferably .beta.-lapachone, or a pharmaceutically acceptable salt, prodrug, metabolite, analog or derivative thereof, protects normal cells against radiation injury. The invention includes methods of preventing radiation damage. The invention also provides methods for treating conditions such as cancer with radiotherapy, by administering a modulator of cell cycle checkpoint activation to a subject, prior to administration of radiotherapy.
L'administration d'un modulateur d'activation de points de contrôle de cycle cellulaire, de préférence, un .beta.-lapachone ou un sel pharmaceutiquement acceptable, un promédicament, un métabolite, un analogue ou un dérivé de celui-ci, protège les cellules normales contre les radiolésions. L'invention concerne des méthodes permettant de prévenir les radiolésions. L'invention concerne également des méthodes permettant de traiter des états tel que le cancer par radiothérapie, par administration d'un modulateur d'activation de points de contrôle de cycle cellulaire à un sujet avant d'administrer ladite radiothérapie.
Hill Stephen A.
Li Chiang J.
Li Youzhi
Arqule Inc.
Mcfadden Fincham
LandOfFree
Use of beta-lapachone for protecting against radiation injury does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of beta-lapachone for protecting against radiation injury, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of beta-lapachone for protecting against radiation injury will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1984455